Clinical trial
Saizen® E-Device User Trial
NCT00450190 · Merck KGaA, Darmstadt, Germany, Industry · Completed
Key facts
| NCT number | NCT00450190 |
|---|---|
| Title | Saizen® E-Device User Trial |
| Official title | User Trial on the Use in Common Practice of a New Electronic Auto-injector of Saizen®, the E-Device (Electronic Device), in Children Treated by Recombinant Human Growth Hormone Over a Period of 2 Months |
| Lead sponsor | Merck KGaA, Darmstadt, Germany, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Disorders |
| Intervention type | Device |
| Interventions | Saizen® E-Device |
| Enrollment | 20 |
| Start date | Feb 28, 2006 |
| Primary completion | Sep 30, 2006 |
| Completion | Sep 30, 2006 |
| First posted | Mar 22, 2007 |
| Last update posted | Jul 23, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: